Restore Medical Receives Breakthrough Device Designation from FDA for ContraBand™ System to Treat HFrEF Patients

OR-YEHUDA, Israel, July 18, 2024 /PRNewswire/ — Restore Medical, a pioneering medical device company in the field of interventional cardiology, is proud to announce that it has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its ContraBand™…